Investigating the Effects of Single Dose and Co-Supplementation of Vitamin D and Omega-3 on Anthropometric Factors, Lipid and Glycemic Profile, and the Status of Sex Hormone Binding Globulin in Women with Polycystic Ovary Syndrome

Shiraz University of Medical Sciences0 个研究点目标入组 107 人开始时间: 待定最近更新: 2022年11月21日

试验速览

暂无简介。

•This syndrome is defined by the Rotterdam Diagnostic Criteria by Gynecologist
•Excluding any drug or surgical treatment to treat clinical symptoms associated with polycystic ovary syndrome except ocp
•No history of any allergy, intolerance or harmful drug reaction to the studied supplements
•Age range ..18-45
•Being within the BMI range of 18.5-40
•Ability to understand study objectives and provide written informed consent
•Residence in Shiraz and willingness to participate in the study

•Suffering from hormonal disorders including Edison's disease, Cushing's disease, hyperparathyroidism, hypo- or hyperthyroidism
•Having history of chronic diseases including cancer, heart disease, diabetes, stroke, fibromyalgia, kidney, or liver defects
•Having history of food and drug allergies
•Starting drug or surgical therapy for clinical symptoms associated with PCOS except oral contraceptive pills (OCPs)
•Smoking or any drug addiction
•Pregnancy and lactation
•Being on a special diet in the last year
•Using any dietary supplement,
•Having oral or injectable nutritional supplements containing vitamin D in the last 3 months
•Consuming nutritional supplements containing fish oil or Omega-3 fatty acids in the last 3 months
•Having fish in the diet more than 3 servings per week during last 3 months
•History of severe side effects or symptoms of poisoning with the current study supplements
•Lack of adherence to the study protocol

发起方